Screening and selection strategy for the establishment of biosimilar to trastuzumab-expressing CHO-K1 cell lines

The high prices of biopharmaceuticals or biologics used in the treatment of many diseases limit the access of patients to these novel therapies. One example is the monoclonal antibody trastuzumab, successfully used for breast cancer treatment. An economic alternative is the generation of biosimilars...

Descripción completa

Detalles Bibliográficos
Autores principales: Lao-Gonzalez, Thailin, Bueno-Soler, Alexi, Duran-Hernandez, Arnelys, Sosa-Aguiar, Katya, Hinojosa-Puerta, Luis Eduardo, Hernandez-Garcia, Tays, de la Luz-Hernandez, Kathya Rashida, Palacios-Oliva, Julio, Boggiano-Ayo, Tammy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778674/
https://www.ncbi.nlm.nih.gov/pubmed/33389203
http://dx.doi.org/10.1186/s13568-020-01157-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778674/
https://www.ncbi.nlm.nih.gov/pubmed/33389203
http://dx.doi.org/10.1186/s13568-020-01157-6

Ejemplares similares